Purchase Order N0017324P5217

Award Date 11/29/23
Potential Completion Date 12/31/23
Potential Value $40K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Coralville, IA 52241, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order awarded by the Office of Naval Research (ONR) to Integrated DNA Technologies, Inc. (IDT) for the delivery of "Integrated DNA Technologies Oligo Cards" over a period ending on September 9, 2024. The contract has a ceiling value of $104,000.00 and is not set aside. IDT is a leading provider of specialized nucleic acid products and services to various federal agencies, including the NIH, CDC, DoD, and Department of Commerce. The company has...
This is a firm-fixed-price purchase order awarded by the National Oceanic and Atmospheric Administration (NOAA) to Integrated DNA Technologies, Inc. (IDT) for the supply of custom DNA oligonucleotides (primers) essential for processing projects in genetics labs. The contract has a ceiling value of $14,745.47 and a completion date of July 12, 2024. IDT is a leading provider of specialized nucleic acid products and services to the U.S. federal government, supporting a wide range of agencies such...
This is a firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services to the U.S. federal government. The $5,040 contract does not have a set-aside designation. Under this contract, IDT is supplying custom DNA and RNA oligonucleotides, gene fragments, next-generation sequencing products, primers, probes, and other reagents to support a...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Integrated DNA Technologies, Inc. (IDT), a prominent manufacturer and supplier of specialized nucleic acid products and services to the U.S. federal government. The contract is for the provision of custom oligonucleotides, reagents, and supplies, with a ceiling value of $34,164.00 and a performance period ending on April 22, 2025. This award is part of IDT's $5 million BPA with...
This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Integrated DNA Technologies, Inc. (IDT) for the provision of biological reagents. The contract has a ceiling value of $26,621.50 and a performance period ending on August 31, 2025. IDT is a leading provider of specialized nucleic acid products and services to the federal government, including custom...
This federal contract award to Integrated DNA Technologies, Inc. (IDT) is for the delivery of custom oligonucleotides to the Defense Health Agency, a defense agency. The $92,050.00 firm-fixed-price contract has an ultimate completion date of August 30, 2024. IDT, a leading provider of specialized nucleic acid products and services to the U.S. federal government, has supported various agencies such as the NIH, CDC, DoD, and Department of Commerce through both prime contracts and subcontracts....
This is a firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services to the U.S. federal government. The $5,040 contract is for the delivery of various nucleic acid-based products and services, including custom DNA and RNA oligonucleotides, gene fragments, next-generation sequencing products, primers, probes, and other reagents for...
This firm-fixed-price purchase order for $114,787.00 was awarded by the National Heart Lung and Blood Institute, a civilian agency within the Department of Health and Human Services, to Integrated DNA Technologies, Inc. (IDT) to provide the ARCHERDx VariantPlex System. The award has no set-aside designation and is expected to be completed by June 23, 2025. IDT is a major provider of specialized nucleic acid products and services to federal agencies. The company frequently supports pandemic...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Integrated DNA Technologies, Inc. (IDT) for $16,438.00 in lab supplies. IDT is a manufacturer of nucleic acid products, including custom DNA and RNA oligonucleotides, gene fragments, next generation sequencing products, primers, probes, reagents, and research materials. IDT has held a Federal Supply Schedule contract with the Department of Veterans Affairs valued at...
This is a firm-fixed-price Blanket Purchase Agreement (BPA) contract awarded by the National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to Integrated DNA Technologies, Inc. (IDT) for the delivery of various biological, oligonucleotide synthesis, and related laboratory supplies and services. The contract has a potential value of up to $100,000,000 and a period of performance through August 31, 2025. IDT, a leading provider of specialized nucleic acid products and...

This is a firm-fixed-price purchase order awarded by the Office of Naval Research to Integrated DNA Technologies, Inc. (IDT) for the supply of IDT Oligocard products. The contract has a total ceiling value of $40,000.00 and an ultimate completion date of December 31, 2023. IDT is a major provider of specialized nucleic acid products and services to federal agencies, supporting pandemic response and biomedical research initiatives. This award was not set aside for any specific business type. IDT also holds an active Federal Supply Schedule contract with the Department of Veterans Affairs, valued at up to $2.5 million, for in vitro diagnostics, reagents, test kits, and related laboratory services.

Generated 6/11/24, 3:53 PM